Andres McAllister
Technik-/Wissenschafts-/F&E-Leiter bei BIOINVENT INTERNATIONAL AB
Vermögen: 7 128 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Björn Frendéus | M | 51 | 23 Jahre | |
Martin Welschof | M | 63 | 6 Jahre | |
Leonard Kruimer | M | 66 | 8 Jahre | |
Alexandre Maret | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 19 Jahre |
Kristoffer Bissessar | M | 56 | 6 Jahre | |
Cecilia Hofvander | F | - | 3 Jahre | |
Stefan Ericsson | M | 61 | 26 Jahre | |
Vincent Ossipow | M | 55 | 8 Jahre | |
Emma Meurling | F | - | - | |
Martin Pålsson | M | 45 | 2 Jahre | |
Marie Moores | F | - | 2 Jahre | |
Natalie Berner | F | 34 | 2 Jahre | |
Ingunn Munch Lindvig | M | - | 1 Jahre | |
Bernd Seizinger | M | 67 | 6 Jahre | |
Sylvie Ryckebusch | M | - | 2 Jahre | |
Kristoffer Rudenholm Hansson | M | 50 | 8 Jahre | |
David Luc Deperthes | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 12 Jahre |
Nanna Liebach Lüneborg | M | 49 | 2 Jahre | |
Erik Esveld | M | - | 3 Jahre | |
Thomas O. Hecht | M | 73 | 4 Jahre | |
Elin Birgersson | F | 39 | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michael Oredsson | M | 64 | 5 Jahre | |
Lars Ingelmark | M | 75 | 12 Jahre | |
Alf Gunnar Martin Nicklasson | M | 69 | 1 Jahre | |
Jane M. Birgitta Stymne Göransson | F | 67 | 2 Jahre | |
Oengus Ramsay | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
Ulrika T. Mattson | F | 56 | 10 Jahre | |
An van Es-Johansson | M | 64 | 5 Jahre | |
Elin Jaensson Gyllenbäck | M | 45 | - | |
Nigel McCracken | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 5 Jahre |
Kamel Besseghir | M | 75 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 17 Jahre |
Niklas Prager | M | 54 | 1 Jahre | |
Pierre Kairouz | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
Dharminder Singh Chahal | M | 48 | 10 Jahre | |
Anette Martensson | F | 42 | - | |
Louise Cavalli | F | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweden | 30 | 83,33% |
Schweiz | 6 | 16,67% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Andres McAllister
- Persönliches Netzwerk